Federal award
BIOMERIEUX INC
HT940823C0022
Contract
Obligated and Ceiling
- Obligated (net)
- $103,972.90
- Ceiling (potential value, not spending)
- $103,972.90
- Current value
- $103,972.90
- Gross positive obligations
- $104,946.66
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- BIOMERIEUX INC · HCNVCMEG9NL6
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- COMPAGNIE MERIEUX ALLIANCE · WG3DJHG5C1C7
- Awarding agency
- Department of War · sub-agency 97DH · office HT9408
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- HT940823C0022
- Award type code
- D
- Actions
- 7 · Sep 29, 2023 to Feb 13, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History7
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 13, 2025 | FY2025 | P00006 | B | −$973.76 | — |
| Oct 21, 2024 | FY2025 | P00005 | C | $36,702.32 | — |
| Sep 26, 2024 | FY2024 | P00004 | G | $0.00 | — |
| Apr 17, 2024 | FY2024 | P00003 | C | $34,954.47 | — |
| Mar 21, 2024 | FY2024 | P00002 | G | $0.00 | — |
| Oct 26, 2023 | FY2024 | P00001 | C | $33,289.87 | — |
| Sep 29, 2023 | FY2023 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.